Not Medicare Enrolled

Dr. Gary Gulish, D.O.

Family Medicine · Wayland, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3587 12TH ST, Wayland, MI 49348
2697922263
In practice since 2006 (20 years)
NPI: 1376572131 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gulish from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gulish? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gulish

Dr. Gary Gulish is a family medicine specialist in Wayland, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gulish performed 101 Medicare services across 74 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gulish received a total of $14,512 from 49 pharmaceutical and/or device companies across 926 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gulish is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 101 Medicare services $14,512 industry payments

Medicare Practice Summary

Medicare Utilization ↗
101
Medicare services
Bottom 18% in MI for family medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
74
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
41 $8 $15
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
38 $43 $105
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $76 $148
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2023 ↗
$14,512
Total received (2018-2023)
Avg $2,419/year across 6 years
Top 2% in MI for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
926
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,512 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$1,220
2022
$2,820
2021
$2,791
2020
$2,324
2019
$2,664
2018
$2,692

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$215
AstraZeneca Pharmaceuticals LP
$198
Bayer Healthcare Pharmaceuticals Inc.
$124
NESTLE HEALTHCARE NUTRITION INC.
$121
Lilly USA, LLC
$110
GlaxoSmithKline, LLC.
$69
E.R. Squibb & Sons, L.L.C.
$63
Takeda Pharmaceuticals U.S.A., Inc.
$39
PFIZER INC.
$36
Kowa Pharmaceuticals America, Inc.
$31
Currax Pharmaceuticals LLC
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Xeris Pharmaceuticals, Inc.
$24
ABBVIE INC.
$22
SANOFI PASTEUR INC.
$21
Amgen Inc.
$21
Teva Pharmaceuticals USA, Inc.
$19
Exact Sciences Corporation
$18
Mylan Specialty L.P.
$18
Antares Pharma, Inc.
$15
Top 3 companies account for 44.0% of 2023 payments
All-time payments by company (2018-2023) ›
AstraZeneca Pharmaceuticals LP
$2,748
Novo Nordisk Inc
$2,450
Lilly USA, LLC
$1,176
Boehringer Ingelheim Pharmaceuticals, Inc.
$848
Janssen Pharmaceuticals, Inc
$782
PFIZER INC.
$753
Amgen Inc.
$573
Kowa Pharmaceuticals America, Inc.
$434
GlaxoSmithKline, LLC.
$398
Amarin Pharma Inc.
$380
ABBVIE INC.
$364
SANOFI-AVENTIS U.S. LLC
$327
Merck Sharp & Dohme Corporation
$325
Mylan Specialty L.P.
$325
AbbVie Inc.
$250
E.R. Squibb & Sons, L.L.C.
$235
Biohaven Pharmaceutical Holding Company Ltd.
$195
Biohaven Pharmaceuticals, Inc.
$152
Astellas Pharma US Inc
$143
Teva Pharmaceuticals USA, Inc.
$126
Bayer Healthcare Pharmaceuticals Inc.
$124
NESTLE HEALTHCARE NUTRITION INC.
$121
Takeda Pharmaceuticals U.S.A., Inc.
$115
Novartis Pharmaceuticals Corporation
$112
Antares Pharma, Inc.
$95
Currax Pharmaceuticals LLC
$88
Radius Health, Inc.
$88
Xeris Pharmaceuticals, Inc.
$83
Nalpropion Pharmaceuticals LLC
$78
Regeneron Healthcare Solutions, Inc.
$61
Bayer HealthCare Pharmaceuticals Inc.
$59
SANOFI PASTEUR INC.
$54
Nabriva Therapeutics, plc
$52
Merck Sharp & Dohme LLC
$46
Allergan, Inc.
$37
Sanofi Pasteur Inc.
$35
Daiichi Sankyo Inc.
$33
Sunovion Pharmaceuticals Inc.
$33
Esperion Therapeutics, Inc.
$30
Edwards Lifesciences Corporation
$27
Orexigen Therapeutics, Inc.
$23
Paratek Pharmaceuticals, Inc.
$21
Exact Sciences Corporation
$18
Electromed, Inc.
$18
DERMIRA, INC.
$18
Vanda Pharmaceuticals Inc.
$17
Supernus Pharmaceuticals, Inc.
$16
Bardy Diagnostics, Inc.
$14
AbbVie, Inc.
$14
Top 3 companies account for 43.9% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ANORO · AUSTEDO · Aimovig · AirDuo Digihaler · Amitiza · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CHANTIX · COLOGUARD · COMIRNATY · CONTRAVE · CREON · Carnation Ambulatory Monitor · Cologuard Collection Kit · DISEASE STATE · Dexilant · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FLUZONE HIGH-DOSE · GARDASIL 9 · GVOKE HYPOPEN · GVOKE PFS · HETLIOZ · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LONHALA MAGNAIR · LYRICA · Livalo · MENACTRA · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NOCDURNA · NURTEC ODT · NUZYRA · ONZETRA XSAIL · Otezla · Ozempic · PENTACEL · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR - 13 · Perforomist · Prolia · QBREXZA · QULIPTA · REYVOW · RYBELSUS · Repatha · Rybelsus · SEEBRI · SEGLENTIS · SMARTVEST · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · Tresiba · Tymlos · UBRELVY · VERQUVO · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xenleta · YUPELRI · Yupelri · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in MI.

Looking for a family medicine specialist in Wayland?
Compare family medicine physicians in the Wayland area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
552
Per 100K population
456.5
County median income
$80,255
Nearest hospital
PINE REST CHRISTIAN MENTAL HEALTH SERVICES
12.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gulish is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 2% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gulish experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Gulish performed 41 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gulish receive payments from pharmaceutical companies?
Yes. Dr. Gulish received a total of $14,512 from 49 companies across 926 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gulish's costs compare to other family medicine physicians in Wayland?
Dr. Gulish's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Gulish) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →